Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease

被引:103
作者
Parkkinen, L
Soininen, H
Alafuzoff, I
机构
[1] Univ Kuopio, Dept Neurol & Neurosci, Sect Neuropathol, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland
[3] Univ Kuopio, Dept Pathol, FIN-70211 Kuopio, Finland
[4] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
a-synuclein; Alzheimer disease; amygdaloid complex; lower brainstem; nucleus basalis of Meynert; substantia nigra;
D O I
10.1093/jnen/62.4.363
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The amygdaloid complex (AC) was found highly vulnerable to alpha-synuclein (alphaS) pathology in both familial and sporadic Alzheimer disease (AD). and recently. incidental Lewy bodies (LBs) were identified primarily in the lower brainstem. This challenges the traditional view that the substantia nigra (SN) is the region that is predominately affected in the spectrum of LB disorders. We examined the immunoreactivity of alphaS in the SN, the nucleus basalis of Meynert (nbM), and the AC in 904 subjects with or without concomitant AD pathology. alphaS-positive structures were seen in at least one of the studied brain areas in 121 subjects (13%). The affected regions in the alphaS-positive subjects included the SN (89%), the nbM (73%), and the AC (67%). This study also included 82 sporadic AD patient,, diagnosed using CERAD criteria. alphaS-positive structures were seen in 32% of the AD patients, with the SN and AC being equally affected. In a few subjects the AC was the only affected area. However, this was not inevitably associated with AD pathology, but was related to cognitive decline. Incidental LBs in the SN were described in the occasional Subjects, with no alphaS pathology in the lower brainstem.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 21 条
[1]
α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation [J].
Arai, Y ;
Yamazaki, M ;
Mori, O ;
Muramatsu, H ;
Asano, G ;
Katayama, Y .
BRAIN RESEARCH, 2001, 888 (02) :287-296
[2]
Where does Parkinson disease pathology begin in the brain? [J].
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Bohl, JRE ;
Braak, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05) :413-426
[3]
Hamilton RL, 2000, BRAIN PATHOL, V10, P378
[4]
HANSEN L, 1990, NEUROLOGY, V40, P1
[5]
NEUROPATHOLOGICAL DIAGNOSES IN ELDERLY PATIENTS IN OSLO - ALZHEIMERS-DISEASE, LEWY BODY DISEASE, VASCULAR-LESIONS [J].
INCE, PG ;
MCARTHUR, FK ;
BJERTNESS, E ;
TORVIK, A ;
CANDY, JM ;
EDWARDSON, JA .
DEMENTIA, 1995, 6 (03) :162-168
[6]
ISEKI E, 1995, NEUROPATHOLOGY, V15, P112
[7]
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease [J].
Jellinger, KA ;
Seppi, K ;
Wenning, GK ;
Poewe, W .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (03) :329-339
[8]
Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P185
[9]
Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies [J].
Kuusisto, E ;
Salminen, A ;
Alafuzoff, I .
NEUROREPORT, 2001, 12 (10) :2085-2090
[10]
Lewy bodies contain altered α-synuclein in brains of many familiar Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes [J].
Lippa, CF ;
Fujiwara, H ;
Mann, DMA ;
Giasson, B ;
Baba, M ;
Schmidt, ML ;
Nee, LE ;
O'Connell, B ;
Pollen, DA ;
George-Hyslop, PS ;
Ghetti, B ;
Nochlin, D ;
Bird, TD ;
Cairns, NJ ;
Lee, VMY ;
Iwatsubo, T ;
Trojanowski, JQ .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05) :1365-1370